본문 바로가기
KERD
논문KCI 등재

A New Integrated Newborn Screening Workflow Can Provide a Shortcut to Differential Diagnosis and Confirmation of Inherited Metabolic Diseases

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: We developed a new workflow design which included results from both biochemical and targeted gene sequencinganalysis interpreted comprehensively. We then conducted a pilot study to evaluate the benefit of this new approach in newbornscreening (NBS) and demonstrated the efficiency of this workflow in detecting causative genetic variants. Materials and Methods: Ten patients in Group 1 were diagnosed clinically using biochemical assays only, and 10 newborns inGroup 2 were diagnosed with suspected inherited metabolic disease (IMD) in NBS. We applied NewbornDiscovery (SD Genomics),an integrated workflow design that encompasses analyte-phenotype-gene, single nucleotide variant/small insertion and deletion/copy number variation analyses along with clinical interpretation of genetic variants related to each participant’s condition. Results: A molecular genetic diagnosis was established in 95% (19/20) of individuals. In Group 1, 13 and 7 of 20 alleles were classifiedas pathogenic and likely pathogenic, respectively. In Group 2, 11 and 6 of 17 alleles with identified causative variants werepathogenic and likely pathogenic, respectively. There were no variants of uncertain significance. For each individual, the NewbornDiscoveryand biochemical analysis results reached 100% concordance, since the single newborn testing negative for causativegenetic variant in Group 2 showed a benign clinical course. Conclusion: This integrated diagnostic workflow resulted in a high yield. This approach not only enabled early confirmation ofspecific IMD, but also detected conditions not included in the current NBS.

Abstract

Purpose: We developed a new workflow design which included results from both biochemical and targeted gene sequencinganalysis interpreted comprehensively. We then conducted a pilot study to evaluate the benefit of this new approach in newbornscreening (NBS) and demonstrated the efficiency of this workflow in detecting causative genetic variants. Materials and Methods: Ten patients in Group 1 were diagnosed clinically using biochemical assays only, and 10 newborns inGroup 2 were diagnosed with suspected inherited metabolic disease (IMD) in NBS. We applied NewbornDiscovery (SD Genomics),an integrated workflow design that encompasses analyte-phenotype-gene, single nucleotide variant/small insertion and deletion/copy number variation analyses along with clinical interpretation of genetic variants related to each participant’s condition. Results: A molecular genetic diagnosis was established in 95% (19/20) of individuals. In Group 1, 13 and 7 of 20 alleles were classifiedas pathogenic and likely pathogenic, respectively. In Group 2, 11 and 6 of 17 alleles with identified causative variants werepathogenic and likely pathogenic, respectively. There were no variants of uncertain significance. For each individual, the NewbornDiscoveryand biochemical analysis results reached 100% concordance, since the single newborn testing negative for causativegenetic variant in Group 2 showed a benign clinical course. Conclusion: This integrated diagnostic workflow resulted in a high yield. This approach not only enabled early confirmation ofspecific IMD, but also detected conditions not included in the current NBS.

참고문헌 (31)

  1. 박경진, "차세대 신생아 선별검사에 대한 전망", Laboratory Medicine Online, 5(4), pp.169~175 (2015), 대한진단검사의학회
  2. Mak CM, "Inborn errors of metabolism and expanded newborn screening: review and update", Crit Rev Clin Lab Sci, 50, pp.142~162 (2013)[DOI]
  3. Schulze A, "Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications", Pediatrics, 111(6), pp.1399~1406 (2003)[DOI]
  4. Bhattacharjee A, "Development of DNA confirmatory and highrisk diagnostic testing for newborns using targeted next-generation DNA sequencing", Genet Med, 17, pp.337~347 (2015)[DOI]
  5. Bodian DL, "Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates", Genet Med, 18, pp.221~230 (2016)[DOI]
  6. Hollegaard MV, "Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing", Mol Genet Metab, 110, pp.65~72 (2013)[DOI]
  7. Richards S, "Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)[DOI]
  8. Li H, "Fast and accurate long-read alignment with Burrows-Wheeler transform", Bioinformatics, 26, pp.589~595 (2010)[DOI]
  9. McKenna A, "The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data", Genome Res, 20, pp.1297~1303 (2010)[DOI]
  10. Wang K, "ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data", Nucleic Acids Res, 38, pp.e164~ (2010)[DOI]
  11. Kumar P, "Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm", Nat Protoc, 4, pp.1073~1081 (2009)[DOI]
  12. Adzhubei IA, "A method and server for predicting damaging missense mutations", Nat Methods, 7, pp.248~249 (2010)[DOI]
  13. Schwarz JM, "Mutation- Taster2: mutation prediction for the deep-sequencing age", Nat Methods, 11, pp.361~362 (2014)[DOI]
  14. Shihab HA, "Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models", Hum Mutat, 34, pp.57~65 (2013)[DOI]
  15. Jian X, "In silico prediction of splice-altering single nucleotide variants in the human genome", Nucleic Acids Res, 42, pp.13534~13544 (2014)[DOI]
  16. Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method", Methods, 25, pp.402~408 (2001)[DOI]
  17. Kim YM, "Determination of autosomal dominant or recessive methionine adenosyltransferase I", III deficiencies based on clinical and molecular studies, 2016, pp.22, 147~155
  18. Chien YH, "Mudd's disease (MAT I", III deficiency): a survey of data for MAT1A homozygotes and compound heterozygotes, 2015, pp.10, 99~
  19. Fernandez-Irigoyen J, "Enzymatic activity of methionine adenosyltransferase variants identified in patients with persistent hypermethioninemia", Mol Genet Metab, 101, pp.172~177 (2010)[DOI]
  20. Lee YW, "Different spectrum of mutations of isovaleryl-CoA dehydrogenase (IVD) gene in Korean patients with isovaleric acidemia", Mol Genet Metab, 92, pp.71~77 (2007)[DOI]
  21. Kim YM, "Novel and recurrent ACADS mutations and clinical manifestations observed in Korean patients with short-chain acyl-coenzyme a dehydrogenase deficiency", Ann Clin Lab Sci, 46, pp.360~366 (2016)
  22. Shirao K, "Molecular pathogenesis of a novel mutation, G108D, in shortchain acyl-CoA dehydrogenase identified in subjects with shortchain acyl-CoA dehydrogenase deficiency", Hum Genet, 127, pp.619~628 (2010)[DOI]
  23. Magoulas PL, "Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management", Orphanet J Rare Dis, 7, pp.68~ (2012)[DOI]
  24. Bennett MJ, "GeneReviews(R)" (1993), University of Washington
  25. Goodman SI, "Glutaric acidemia type II: gene structure and mutations of the electron transfer flavoprotein:ubiquinone oxidoreductase (ETF:QO) gene", Mol Genet Metab, 77, pp.86~90 (2002)[DOI]
  26. Filippo CA, "Glycosylation of the OCTN2 carnitine transporter: study of natural mutations identified in patients with primary carnitine deficiency", Biochim Biophys Acta, 1812, pp.312~320 (2011)[DOI]
  27. Wiltink RC, "Neonatal screening for profound biotinidase deficiency in the Netherlands: consequences and considerations", Eur J Hum Genet, 24, pp.1424~1429 (2016)[DOI]
  28. Therrell BL, "Current status of newborn screening worldwide: 2015", Semin Perinatol, 39, pp.171~187 (2015)[DOI]
  29. Howard HC, "Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes", Eur J Hum Genet, 23, pp.1593~1600 (2015)[DOI]
  30. Berg JS, "Potential uses and inherent challenges of using genome-scale sequencing to augment current newborn screening", Cold Spring Harb Perspect Med, 5, pp.a023150~ (2015)
  31. Kim SH, "Mutations of ACADS gene associated with short-chain acyl-coenzyme A dehydrogenase deficiency", Ann Clin Lab Sci, 41, pp.84~88 (2011)

관련 논문AI추천

Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry윤혜란대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2015 · 제20권 제3호Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry윤혜란대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2015 · 제20권 제4호A Population-Based Genomic Study of Inherited Metabolic Diseases Detected Through Newborn Screening김종원, 박경진, 박승만, 박종호, 박준희, 박형두, 이수연, 이은희대한진단검사의학회 · Annals of Laboratory Medicine2016 · 제36권 제6호Rapid Targeted Sequencing Using Dried Blood Spot Samples for Patients With Suspected Actionable Genetic Diseases고정민, 성문우, 채종희, Choi Wooyong, Jung Ju Yeol, Kang Sanggoo, Kim Man Jin, Kim Soo Yeon, Kim Taehyung, Lee Jin Sook, Park Lae-Jeong, Park Sung Sup대한진단검사의학회 · Annals of Laboratory Medicine2023 · 제43권 제3호Clinical, Biochemical and Genetic Analyses in Two Korean Patients with Medium-chain Acyl-CoA Dehydrogenase Deficiency기창석, 김종원, 박형두, 우혜인, 이동환, 이수연, 이용화대한진단검사의학회 · Annals of Laboratory Medicine2011 · 제31권 제1호A Novel MUT Gene Mutation Detected in a Female Infant with Methylmalonic Acidemia박형두, Byung Jin Song, Won Duck Kim, Woo Sun Song대한신생아학회 · Neonatal medicine2015 · 제22권 제1호

이 간행물의 다른 논문 (8건)